Showing results (31-40 of 67) with videos related to
Sort By:
Pageof 7
Leukemia & Lymphoma|March 30, 2017
Immunotherapy of elderly acute myeloid leukemia: light at the end of a long tunnel?William M Rafelson, John L Reagan, Loren D Fast, et al.Annals of Hematology|September 2, 2020
Antibiotic use during cytarabine consolidation in acute myeloid leukemiaColin A Vale, Pamela C Egan, Randall Ingham, et al.Blood|October 24, 2002
Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantationGudrun Ratzinger, John L Reagan, Glenn Heller, et al.Thrombosis Research|September 27, 2020
Intensity of anticoagulation and survival in patients hospitalized with COVID-19 pneumoniaAndrew Hsu, Yuchen Liu, Adam S Zayac, et al.Leukemia & Lymphoma|September 11, 2020
Adjuvant chemotherapy administration and survival outcomes of lymphoma survivors with common solid tumors: a population-based study†Mengyang Di, Orestis A Panagiotou, John L Reagan, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 4, 2021
Tumor lysis syndrome risk in outpatient versus inpatient administration of venetoclax and hypomethlators for acute myeloid leukemiaAri Pelcovits, Jozal Moore, Brianna Bakow, et al.Clinical Lymphoma, Myeloma & Leukemia|July 3, 2019
Prevalence and Effect on Survival of Pulmonary Hypertension in MyelofibrosisMatthew Austin, Peter J Quesenberry, Corey E Ventetuolo, et al.Journal of Thrombosis and Thrombolysis|May 23, 2023
Choice of anticoagulation in patients with low risk antiphospholipid syndromeBrianna R Bakow, Quan Phung, David Rabinovich, et al.Case Reports in Gastroenterology|April 3, 2025
Coexisting Collagenous Sprue and Celiac Disease: A Case ReportTyler M Selig, Ayesha Siddique, John L Reagan, et al.Thrombosis Research|May 17, 2014
Differences in the clinical course of heparin induced thrombocytopenia before and after the availability of HIT IgG class testingJohn L Reagan, Randall R Ingham, Samir Dalia, et al.Pageof 7